ruxolitinib phosphate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
15 FDA-registered drug labelers
Alivus Life Sciences Limited
American Pacific Corporation
AX Pharmaceutical Corp
Chongqing Huapont Pharmaceutical Co., Ltd
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Finorga
Granules India Limited
Incyte Corporation
Melody Healthcare Pvt. Ltd.
MSN Laboratories Private Limited
Natco Pharma Limited
Siegfried Evionnaz SA
Siegfried USA, LLC
VALARY LAB PRIVATE LIMITED
Zhejiang Ausun Pharmaceutical Co., Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Opzelura
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS1092939-17-7
PubChem CID25127112
DTXSIDDTXSID00911086
FormulaC17H21N6O4P
Mol. Weight404.4 g/mol
SMILESC1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O
Data Sources
251271122026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/ruxolitinib phosphate/cids/JSON
Archive: data/sources/pubchem_name/ruxolitinib phosphate.json
CAS 1092939-17-72026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json